Flor Á. Ordóñez

552 total citations
16 papers, 383 citations indexed

About

Flor Á. Ordóñez is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Flor Á. Ordóñez has authored 16 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Flor Á. Ordóñez's work include Growth Hormone and Insulin-like Growth Factors (6 papers), Parathyroid Disorders and Treatments (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Flor Á. Ordóñez is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (6 papers), Parathyroid Disorders and Treatments (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Flor Á. Ordóñez collaborates with scholars based in Spain, United States and Italy. Flor Á. Ordóñez's co-authors include Fernando Santos, Helena Gil‐Peña, Julián Rodrı́guez, O. Alvarez-Garcia, Rocío Fuente, Natalia Mejía, S Málaga, Victoria Álvarez, Eliécer Coto and Dieter Haffner and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Kidney International.

In The Last Decade

Flor Á. Ordóñez

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Flor Á. Ordóñez Spain	12	177	166	49	47	47	16	383
Annelies De Maré Belgium	8	193 1.1×	162 1.0×	51 1.0×	41 0.9×	50 1.1×	9	407
Macarena Orejudo Spain	13	143 0.8×	190 1.1×	48 1.0×	41 0.9×	29 0.6×	25	600
Hitomi Hama Japan	10	215 1.2×	129 0.8×	42 0.9×	26 0.6×	34 0.7×	13	425
Lara Valiño‐Rivas Spain	14	285 1.6×	225 1.4×	44 0.9×	39 0.8×	25 0.5×	23	602
Akihiro Shimomura Japan	10	219 1.2×	114 0.7×	27 0.6×	52 1.1×	21 0.4×	22	415
Daphne H.T. IJpelaar Netherlands	8	246 1.4×	117 0.7×	51 1.0×	59 1.3×	37 0.8×	17	466
Britt Opdebeeck Belgium	10	300 1.7×	187 1.1×	73 1.5×	72 1.5×	40 0.9×	18	568
Jin Tian United States	8	292 1.6×	105 0.6×	70 1.4×	72 1.5×	62 1.3×	8	537
Yong‐Ke You China	11	219 1.2×	400 2.4×	36 0.7×	61 1.3×	53 1.1×	17	686
Kenichi Koga Japan	9	143 0.8×	210 1.3×	44 0.9×	50 1.1×	21 0.4×	22	477

Countries citing papers authored by Flor Á. Ordóñez

Since Specialization

Citations

This map shows the geographic impact of Flor Á. Ordóñez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flor Á. Ordóñez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flor Á. Ordóñez more than expected).

Fields of papers citing papers by Flor Á. Ordóñez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flor Á. Ordóñez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flor Á. Ordóñez. The network helps show where Flor Á. Ordóñez may publish in the future.

Co-authorship network of co-authors of Flor Á. Ordóñez

This figure shows the co-authorship network connecting the top 25 collaborators of Flor Á. Ordóñez. A scholar is included among the top collaborators of Flor Á. Ordóñez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flor Á. Ordóñez. Flor Á. Ordóñez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cara‐Fuentes, Gabriel, Rakesh Kumar Verma, Madhusudan Venkatareddy, et al.. (2022). β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease. SHILAP Revista de lepidopterología. 44(1). 90–99. 1 indexed citations

Piani, Federica, et al.. (2021). Molecular Mechanisms of Proteinuria in Minimal Change Disease. Frontiers in Medicine. 8. 761600–761600. 20 indexed citations

Piani, Federica, Flor Á. Ordóñez, Carmen de Lucas Collantes, et al.. (2021). Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation. Kidney International Reports. 7(4). 797–809. 15 indexed citations

Santos, Fernando, et al.. (2021). Bone Disease in CKD in Children. Calcified Tissue International. 108(4). 423–438. 14 indexed citations

Gil‐Peña, Helena, et al.. (2017). Effects of growth hormone treatment on growth plate, bone, and mineral metabolism of young rats with uremia induced by adenine. Pediatric Research. 82(1). 148–154. 6 indexed citations

Santos, Fernando, et al.. (2015). Clinical and laboratory approaches in the diagnosis of renal tubular acidosis. Pediatric Nephrology. 30(12). 2099–2107. 40 indexed citations

Gil‐Peña, Helena, et al.. (2015). Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia. American Journal of Physiology-Renal Physiology. 309(1). F57–F62. 52 indexed citations

Alvarez-Garcia, O., Helena Gil‐Peña, Natalia Mejía, et al.. (2012). Growth Hormone Improves Growth Retardation Induced by Rapamycin without Blocking Its Antiproliferative and Antiangiogenic Effects on Rat Growth Plate. PLoS ONE. 7(4). e34788–e34788. 14 indexed citations

Santos, Fernando, et al.. (2012). Hypophosphatemia and growth. Pediatric Nephrology. 28(4). 595–603. 47 indexed citations

10.

Alvarez-Garcia, O., et al.. (2010). Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate. Kidney International. 78(6). 561–568. 37 indexed citations

11.

Gil‐Peña, Helena, et al.. (2009). Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment. American Journal of Physiology-Renal Physiology. 297(3). F639–F645. 16 indexed citations

12.

Santos, Fernando, et al.. (2007). Distal RTA with nerve deafness: clinical spectrum and mutational analysis in five children. Pediatric Nephrology. 22(6). 825–828. 33 indexed citations

13.

Alvarez-Garcia, O., et al.. (2007). Rapamycin retards growth and causes marked alterations in the growth plate of young rats. Pediatric Nephrology. 22(7). 954–961. 51 indexed citations

14.

Ordóñez, Flor Á., et al.. (2000). Resistance to growth hormone and insulin-like growth factor-I in acidotic rats. Pediatric Nephrology. 14(8-9). 720–725. 26 indexed citations

15.

Balbı́n, Milagros, et al.. (1999). Hepatic expression of growth hormone receptor/binding protein and insulin-like growth factor I genes in uremic rats. Influence of nutritional deficit. Growth Hormone & IGF Research. 9(1). 61–68. 7 indexed citations

16.

Ordóñez, Flor Á., et al.. (1998). Rat models of normocalcemic hypercalciuria of different pathogenic mechanisms. Pediatric Nephrology. 12(3). 201–205. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact